Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000093

Chief Medical Officer sold 11,365 shares at $12.93 ($146,987)

  • Chief Medical Officer acquired 6,349 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2025-08-12 Option exercise 10b5-1 +6,349 $1.08 $6,857 104,256 D
Rodman David Malcom Chief Medical Officer 2025-08-13 Sale 10b5-1 −11,365 $12.93 $146,987 92,891 D
Derivatives
Rodman David Malcom Chief Medical Officer 2025-08-12 Option exercise · Stock Option 10b5-1 −6,349 82,531 D
Open-market sales · 11,365 sh · avg $12.93 · $146,987
Loading xslF345X05/wk-form4_1755208973.xml…